Fredun Pharmaceuticals Expands Pet-Wellness Brand Furlicks From 6 to 22 SKUs
Fredun Pharmaceuticals Ltd · Press Release · 15 Sept 2026, 3:57 pm
Fredun Pharmaceuticals Expands Pet-Wellness Brand Furlicks From 6 to 22 SKUs Fredun Pharmaceuticals Limited (FPL) announced a major phase-wise portfolio expansion for its acquired pet-wellness brand, Furlicks, expanding its lineup from 6 to 22 SKUs over the next 6–9 months. The rollout introduces 16 new products across diverse formats, moving beyond oral-dissolving strips into cold-extruded, air-dried, freeze-dried products, and functional biscuits. This expansion aims to build Furlicks into a differentiated, multi-format pet-wellness platform across India by leveraging FPL's internal manufacturing, R&D, and product development capabilities.
Original exchange filing (PDF)
More announcements from Fredun Pharmaceuticals Ltd
- Audio Recording Q2 & H1 FY27 Earnings Conference Call of Fredun Pharmaceuticals Limited. · 16 Nov 2026
- Outcome of the Board Meeting of 'Fredun Pharmaceuticals Limited' ('Company') pursuant to Regulation 30 of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. · 14 Nov 2026
- Report of Monitoring Agency on the use of proceeds raised through Preferential Allotment for the quarters ended March 31, 2026, June 30,2026 and September30, 2026. · 14 Nov 2026
- Statement of Deviation or Variation For the Quarter Ended September 30, 2026 for the Funds raised through Preferential Issue. · 14 Nov 2026
- Intimation of Earnings Conference Call for the Quarter Q2 of FY27 · 16 Nov 2026
- Press Release · 06 Nov 2026
- Approval for National Stock Exchange of India Limited (NSE) Listing Application. · 05 Nov 2026
- Financial results for the quarter ended 30th September, 2026. · 05 Nov 2026
